Suzhou Ribo Life Science Co. Ltd.

This early-stage study tests the safety and tolerability of a new drug called RBD1119 in 32 healthy adults aged 18 to 65. Participants receive a single injection under the skin, and researchers monitor for side effects and how the drug moves through the body. The goal is to gathe…